Results 181 to 190 of about 44,739 (224)

Association between cardiometabolic index and overactive bladder in U.S. adults: findings from NHANES [2017-2020]. [PDF]

Transl Androl Urol
Chen J, Zhang W, Zhang Z, Tang Q, Liu B, Nie Z, Gao X, Qiu J, Xu G.   +8 more
europepmc   +1 more source

9 Percutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome: a single-arm trial

H Kyaw, Hannah Krause, Judith Goh
openalex   +2 more sources

An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder. [PDF]

Medicine (Baltimore)
Bai WZ, Zhou SY, Mou YY, Peng L, Li LL.
europepmc   +1 more source

Depression mediates the association between lipid accumulation products and overactive bladder. [PDF]

Sci Rep
Huang C, Xu Y, Guan Y, Liu J, Yang H.
europepmc   +1 more source

Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice

, 2019
Marcos Fiuza de Carvalho, Thuliermes Lopes Pamplona, Márcio Alencar Barreira, Francisco Vagnaldo Jacuru Fechine, Lúcio Flávio Gonzaga-Silva, Ricardo Reges Maia de Oliveira   +5 more
openalex   +1 more source

Alterations in urinary microbiota composition in children with overactive bladder: insights from 16S rRNA gene sequencing. [PDF]

Sci Rep
Li J, Yu L, Wang Y, Yuan C, Wang K, Ma X.   +5 more
europepmc   +1 more source

Correction: Barriers to early and effective overactive bladder management in male patients with lower urinary tract symptoms. [PDF]

PLoS One
Rasner P, Arcila-Ruiz M, Silva JAF, Nuanthaisong U, Cho SY, Chung E.   +5 more
europepmc   +1 more source

Concomitant Overactive Bladder Treatment and Adherence to Pelvic Floor Physical Therapy. [PDF]

Int Urogynecol J
Ashmore S, Steinbeck A, Scioscia N, Weaver A, Sassani JC.   +4 more
europepmc   +1 more source

Effects of behavioral treatment and pelvic floor muscle training on overactive bladder syndrome: a randomized control trial. [PDF]

Braz J Phys Ther
Matias MMP, Fitz FF, Gimenez MM, Ferreira LA, Bortolini MAT, Castro RA.   +5 more
europepmc   +1 more source

Clinician- and Geographic-Level Variation in Utilization of Sacral Neuromodulation and OnabotulinumtoxinA Injections Among Medicare Beneficiaries With Overactive Bladder. [PDF]

Urology
Dreyfuss LD, Wang L, Nik-Ahd F, Shatkin-Margolis A, Covinsky K, John Boscardin W, Suskind AM.   +6 more
europepmc   +1 more source